CD4 and neoplasm: The protein was found to have low regressions in the tumor and stromal compartments between blocks of YTMA454, a high correlation between its expression in the tumor versus stromal compartment, and modest correlations of expression with CD4 and CD8 in patients relative to other TIL and CAF markers.